Literature DB >> 3518433

International experiences with diclofenac in osteoarthritis.

R Altman.   

Abstract

Despite a wide range of study designs, a multiplicity of international trials of diclofenac in osteoarthritis have disclosed similar results. These include double-blind comparisons with indomethacin, aspirin, naproxen, ibuprofen, sulindac, and diflunisal, as well as open trials from European field studies. The results of this review document that diclofenac is as effective as other nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518433     DOI: 10.1016/0002-9343(86)90080-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Efficacy and tolerability of diclofenac dispersible in painful osteoarthrosis.

Authors:  R Bakshi; N Ezzet; L Frey; D Lasry; D Salliere
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

2.  Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules.

Authors:  S Y Lin; Y H Kao
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

Review 3.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

4.  Economic evaluation of tramadol/paracetamol combination tablets for osteoarthritis pain in the Netherlands.

Authors:  Hiltrud Liedgens; Mark J C Nuijten; Barbara Poulsen Nautrup
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

5.  Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis.

Authors:  D E Ward; E M Veys; J M Bowdler; J Roma
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

6.  Single intramuscular injection of diclofenac sodium in febrile pediatric patients.

Authors:  Jun Yeol Lee; Jun Hwi Cho; Myoung Cheol Shin; Taek Geun Ohk; Hui Young Lee; Chan Woo Park
Journal:  Indian J Pharmacol       Date:  2015 May-Jun       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.